A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases

Tocilizumab (TCZ) is the first humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody approved for the treatment of patients with rheumatoid arthritis (RA), Castleman’s disease, polyarticular and systemic juvenile idiopathic arthritis, and, most recently, giant cell arteritis as well as fo...

Full description

Saved in:
Bibliographic Details
Published in:Rheumatol Ther
Main Authors: Rubbert-Roth, Andrea, Furst, Daniel E., Nebesky, Jan Michael, Jin, Angela, Berber, Erhan
Format: Artigo
Language:Inglês
Published: Springer Healthcare 2018
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5935615/
https://ncbi.nlm.nih.gov/pubmed/29502236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-018-0102-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items